CompletedInterventionalPhase 2Phase 3Updated May 30, 2011
A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief | NCT02455050 | Trialant
CompletedInterventionalPhase 3Updated Jan 4, 2017
A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief
ClinicalTrials.gov ID
NCT02455050
Lead Sponsor
AllerganINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 3
Enrollment
79Actual
Last Update Posted
Jan 4, 2017Estimated
Start Date
Dec 2014
Primary Completion Date
Aug 2015Actual
Completion Date
Aug 2015Actual
Brief Summary
A study to evaluate the tolerability and acceptability of an investigational eye drop formulation in patients with Dry Eye Disease.
Dry Eye Syndromes
Carboxymethylcellulose Sodium Based Eye Drops
Systane® Gel Drops
Genteal® Lubricant Gel Drops
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Current use of an artificial tear product
Visual Acuity of at least 20/40 (while wearing glasses, if necessary).
Exclusion Criteria:
Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study
Cataract surgery, laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy within 6 months
Use of RESTASIS® Cyclosporine Ophthalmic Emulsion or any topical cyclosporine within 3 months